Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2026-01-30
• Last 15 days FTD volume: £0 M
• Last 3 months FTD volume: £0.46 M
• Last 12 months FTD volume: £4.34 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	£61.7 M	£0.13 B	🇺🇸 USA
Merck MRK	£0.10 B	£0.21 B	🇺🇸 USA
GSK plc GSK	£23.88 M	£0.36 B	🇬🇧 UK
Soligenix SNGX	£0.52 M	£13.98 M	🇺🇸 USA
SIGA Technologies SIGA	£0.1 M	£0.98 M	🇺🇸 USA
Celldex Therapeutics CLDX	£6.19 M	£10.74 M	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	£54.14 M	£86.35 M	🇮🇱 Israel